SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Thure Meyer who wrote (624)2/23/1998 2:53:00 PM
From: tommysdad  Read Replies (2) of 1837
 
Wyeth-Ayerst's Premarin, at which this product is directly aimed, is the one of the leading prescription medications in the U.S. ($800M ++ in sales). Obviously, DRMD will not take all the market share and WAR has launched a massive direct-marketing campaign praising Premarin, but 10% of this market would be a lot for DRMD and 25% would be huge. DRMD does have an interesting marketing hook based solely on the source of their conjugated estrogens vs. WAR's urine-based drug.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News